Largest route
IRL to BEL$3.4BTrade Corridor Access Planner
Trade corridors for containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale
A reported trade view for HS 300339, with available observations through 2024.
Explore this productDisplayed routes
100Reported corridorsMedian distance
1,444 kmDisplayed routesLatest global trade
$4.5BYear: 2024Reported observations
Route access evidence
Routes ranked by latest reported trade value. Buyer-market and route fields are shown when reported.
| Route | Route trade | 5-year growth | Buyer imports | Supplier countries | Applied tariff | Distance |
|---|---|---|---|---|---|---|
| Ireland to Belgium | $3.4B | +679.3% | $3.4B | 12 | 0% | 776 km |
| USA to Germany | $84.6M | +29.6% | $108.0M | 29 | 0.1% | 6,035 km |
| Poland to Denmark | $74.6M | +3.1% | $259.0M | 30 | 0% | 669 km |
| USA to Switzerland, Liechtenstein | $73.4M | -1.7% | $78.2M | 15 | 0% | 6,272 km |
| Denmark to Poland | $72.9M | +19.2% | $76.0M | 17 | 0.1% | 669 km |
| USA to Netherlands | $64.3M | +352.4% | $69.8M | 28 | 0.1% | 5,866 km |
| USA to Denmark | $55.0M | +82.7% | $259.0M | 30 | 0.1% | 6,192 km |
| USA to Ireland | $53.4M | +6.9% | $64.9M | 18 | 0.1% | 5,118 km |
| Denmark to Sweden | $32.2M | +12.8% | $34.3M | 15 | 0% | 524 km |
| China to Denmark | $25.8M | +930.4% | $259.0M | 30 | 0% | 7,208 km |
| Denmark to USA | $25.6M | +99.2% | $62.8M | 22 | 0% | 6,192 km |
| Belgium to USA | $23.6M | +50.4% | $62.8M | 22 | 0% | 5,892 km |
| Germany to Denmark | $19.6M | +30.3% | $259.0M | 30 | 0% | 596 km |
| Kuwait to United Arab Emirates | $16.2M | +52% | $16.5M | 15 | 0% | 836 km |
| Denmark to Germany | $16.0M | +56% | $108.0M | 29 | 0% | 596 km |
| Kuwait to Saudi Arabia | $15.6M | +36.5% | $16.5M | 14 | 0.1% | 535 km |
| South Africa to Namibia | $15.2M | +8.6% | $18.1M | 49 | 0% | 1,272 km |
| Denmark to Norway | $14.7M | +43.9% | $22.2M | 8 | 0% | 485 km |
| Pakistan to Afghanistan | $14.1M | +20.5% | $14.4M | 5 | 0% | 375 km |
| China to India | $12.8M | +10.8% | $21.6M | 14 | 0.5% | 3,785 km |
| Canada to Ireland | $11.0M | -16.7% | $64.9M | 18 | 0.1% | 5,257 km |
| Netherlands to Denmark | $10.8M | +27.2% | $259.0M | 30 | 0% | 623 km |
| India to USA | $8.7M | +66.4% | $62.8M | 22 | 0% | 11,762 km |
| Netherlands to India | $8.0M | +120.1% | $21.6M | 14 | 0.5% | 6,363 km |
| Austria to Italy | $7.7M | +201% | $18.9M | 22 | 0% | 767 km |
| Portugal to Canada | $7.3M | +401.5% | $13.3M | 14 | 0.1% | 5,731 km |
| Spain to Denmark | $7.2M | +47.4% | $259.0M | 30 | 0% | 2,075 km |
| Bulgaria to Denmark | $7.0M | +26.4% | $259.0M | 30 | 0% | 1,639 km |
| Germany to Japan | $6.7M | -4.4% | $11.0M | 8 | 0% | 9,298 km |
| Poland to Norway | $6.5M | +24.2% | $22.2M | 8 | 0.1% | 1,062 km |
| France to Denmark | $6.5M | +16.1% | $259.0M | 30 | 0% | 1,028 km |
| Spain to Ireland | $6.2M | +166.5% | $64.9M | 18 | 0% | 1,450 km |
| Ireland to Canada | $6.1M | +20.6% | $13.3M | 14 | 0.1% | 5,257 km |
| Romania to Denmark | $6.0M | +22.5% | $259.0M | 30 | 0% | 0 km |
| Portugal to Denmark | $5.8M | +37.9% | $259.0M | 30 | 0% | 2,478 km |
| Italy to Denmark | $5.7M | +20.1% | $259.0M | 30 | 0% | 1,534 km |
| Greece to Denmark | $5.4M | +26.1% | $259.0M | 30 | 0% | 2,136 km |
| USA to Canada | $5.4M | +6.2% | $13.3M | 14 | 0% | 548 km |
| Czechia to Denmark | $5.0M | +13.3% | $259.0M | 30 | 0% | 632 km |
| Ireland to Germany | $4.9M | +113.8% | $108.0M | 29 | 0% | 921 km |
Market reading
Which containing hormones (excluding insulin), (but not containing antibiotics), for therapeutic or prophylactic uses, not packaged for retail sale trade routes matter most?
The leading reported route is Ireland to Belgium, with trade value of $3.4B.
How to use this view
Start with the leading rows in the first table to compare the reported observations available for this view. The second table adds a related reported comparison.
Coverage extends to 2024. Missing values are shown as not reported.
Further comparison
Selected route history
Annual reported trade and change for the featured route.
| Year | Route trade | Year-on-year change | 3-year growth |
|---|---|---|---|
| 2010 | $611.2K | -66.4% | +19% |
| 2011 | $288.1K | -52.9% | -13.3% |
| 2012 | $761.0K | +164.1% | -25.2% |
| 2013 | $1.1M | +40.3% | +20.4% |
| 2014 | $698.3K | -34.6% | +34.3% |
| 2015 | $773.5K | +10.8% | +0.5% |
| 2016 | $558.5K | -27.8% | -19.4% |
| 2017 | $670.5K | +20% | -1.3% |
| 2018 | $435.3K | -35.1% | -17.4% |
| 2019 | $119.0K | -72.7% | -40.3% |
| 2020 | $554.4M | +465,723.8% | +838.6% |
| 2021 | $2.7K | -100% | -81.6% |
| 2022 | $866.0M | +31,795,937.7% | +1,837.8% |
| 2023 | $2.5B | +184.9% | +64.5% |
| 2024 | $3.4B | +38.6% | +10,688.4% |
Explore related views
Continue with another perspective on this product.
Latest observed year: 2024. Page updated 2026-08-14.
Source and date
Reported merchandise-trade observations for HS6 products. Coverage shown on this page: 1995-2024. Updated 2026-08-14.
Definitions
Trade value is reported in current US dollars. Unit value is trade value divided by reported quantity and is shown per metric ton where available. Growth is an annualized or year-on-year calculation from reported values.
Reading the data
“Not reported” means a value was not available for this view. Values can be revised as reporting is updated. See the methodology for coverage and classification details.